Goin Kathleen's Form 4 filing
Palvella Therapeutics, Inc. (PVLA) · filed Feb 20, 2026
- Accession no.
- 0001104659-26-018136
- Filed
- Feb 20, 2026
- Trade date
- Feb 18, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $341.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Goin KathleenCIK 0001912570 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | Common Stock | MOption exerciseAcquired | +2,154 | $7.14 | +$15,379.56 | 2,154 | Direct | |
| Feb 18, 2026 | Common Stock | MOption exerciseAcquired | +2,148 | $9.08 | +$19,503.84 | 4,302 | Direct | |
| Feb 18, 2026 | Common Stock | SSaleDisposed | −3,026 | $79.16 | −$239,538.16 | 1,276 | Direct | |
| Feb 18, 2026 | Common Stock | SSaleDisposed | −1,276 | $79.97 | −$102,041.72 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | Common Stock | MOption exerciseDisposed | −2,154 | $0.00 | $0 | 17,243 | Direct | |
| Feb 18, 2026 | Common Stock | MOption exerciseDisposed | −2,148 | $0.00 | $0 | 17,184 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.